AJR 2005; 184:83-90
© American Roentgen Ray Society
Transient Hepatic Attenuation Differences in Focal Hepatic Lesions: Dynamic CT Features
Hyoung Jung Kim1,
Ah Young Kim1,
Tae Kyoung Kim1,
Jae Ho Byun1,
Hyung Jin Won1,
Kyoung Won Kim1,
Yong Moon Shin1,
Pyo Nyun Kim1,
Hyun Kwon Ha1 and
Moon-Gyu Lee1
1 All authors: Department of Radiology, Asan Medical Center, University of Ulsan
College of Medicine, 388-1, Poongnap-dong, Songpa-Ku, Seoul, South
Korea.
Received March 9, 2004;
accepted after revision June 14, 2004.
Address correspondence to A. Y. Kim.
Introduction
The widespread use of dual-phase dynamic CT has led to an improvement in
the characterization and detection of focal hepatic lesions by highlighting
the dynamic contrast-enhancement features. Transient hepatic attenuation
difference (THAD) is an attenuation difference of the liver appearing during
bolus-enhanced dynamic CT and not corresponding to mass
[1]. THAD is generally seen as
an area of high attenuation on the hepatic arterial phase image that returns
to normal attenuation on the portal venous phase image. THADs that are
associated with hepatic tumors are generally characteristic of malignant
tumors. However, benign focal lesions, such as hemangiomas, focal nodular
hyperplasia, pyogenic abscesses, and focal eosinophilic necrosis, may
accompany THADs. Hepatic hemodynamic alterations caused by liver cirrhosis and
aberrant blood supply may show findings similar to those of THADs in focal
hepatic lesions.
Malignant Focal Hepatic Lesions
Hepatocelluar Carcinoma
Hepatocellular carcinoma (HCC) is the most common primary hepatic tumor
associated with the THAD. Okuda et al.
[2] reported that arterioportal
shunts occurred in 63% of cases of HCC (second-order and larger portal vein in
41% and third-order and smaller branch in 22%). Various routes, such as the
transplexal, transsinusoidal, transvasal, or transtumoral route, may be the
communication between the hepatic artery and the portal vein. However, if a
HCC is located in the peripheral portion of the liver and is small, it rarely
compromises the portal or hepatic vein and may show THAD through the
transtumoral route (Figs. 1A,
1B, and
1C). In a study using dynamic
CT and focused on HCCs less than 3 cm, Byun et al.
[3] noted THAD in only 4% of
the tumors.

View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A. 40-year-old man with hepatocellular carcinoma (HCC). Hepatic
arterial phase CT scan shows small high-attenuation tumor (arrow) in
posterior segment and homogeneous high-attenuation area (arrowheads)
peripheral to tumor. It is difficult to estimate extent of tumor on hepatic
arterial phase image.
|
|

View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B. 40-year-old man with hepatocellular carcinoma (HCC). Portal
venous phase CT scan shows discrete extent of HCC (arrow) because
transient hepatic attenuation difference no longer exists.
|
|
Peripheral Cholangiocarcinoma
When cholangiocarcinoma is located adjacent to the hilar portion of the
liver, it frequently shows THAD of lobar distribution on hepatic arterial
phase images (Figs. 2A,
2B, and
2C). THAD is an important
indirect sign of vascular invasion. Peripheral cholangiocarcinoma may have a
risk of vascular involvement, especially in the peripheral branch of the
portal vein (Figs. 3A and
3B). The reported incidence of
THAD in peripheral cholangiocarcinoma on dynamic CT is from 29% to 45%
[4,
5].

View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A. 53-year-old man with cholangiocellular carcinoma. Hepatic
arterial phase CT scans show diffuse high attenuation in left lobe (A)
and low-attenuation mass with peripheral rim enhancement (B). Left
portal vein is partially obliterated by tumor (arrow, B).
Transient hepatic attenuation difference (THAD) on hepatic arterial phase CT
scan is due to increased arterial flow as compensation for compromised portal
vein flow.
|
|

View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B. 53-year-old man with cholangiocellular carcinoma. Hepatic
arterial phase CT scans show diffuse high attenuation in left lobe (A)
and low-attenuation mass with peripheral rim enhancement (B). Left
portal vein is partially obliterated by tumor (arrow, B).
Transient hepatic attenuation difference (THAD) on hepatic arterial phase CT
scan is due to increased arterial flow as compensation for compromised portal
vein flow.
|
|

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2C. 53-year-old man with cholangiocellular carcinoma. Portal
venous phase CT scan still shows diffuse high attenuation in left lobe and
parenchymal atrophy. Left hepatic vein branch (arrow) is not
opacified because of tumor invasion (not shown). Persistent THAD up to portal
venous phase may be due to concurrent obstruction of left hepatic vein
branch.
|
|

View larger version (81K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3A. 62-year-old man with cholangiocellular carcinoma. Hepatic
arterial phase CT scan shows peripheral rim enhancement of tumor and
associated wedge-shaped high-attenuation area (arrows) in posterior
segment.
|
|
Metastasis
To the best of our knowledge, there is no report of the incidence and
pathogenesis of THAD of hepatic metastasis. However, some of the metastases
may accompany the wedge-shaped high-attenuation areas on hepatic arterial
phase images. Hypervascular metastases such as islet cell tumors, carcinoids,
renal cell carcinoma, and breast cancer, may show THAD (Figs.
4A and
4B). If we consider that the
various tumors eliciting THAD are hypervascular, it is not surprising that
hypervascular metastasis shows THAD.

View larger version (129K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A. 52-year-old man with metastases from neuroendocrine tumor of
pancreas. Hepatic arterial phase CT scan shows two hypervascular hepatic
metastases associated with peripheral wedge-shaped high-attenuation area
(arrows).
|
|

View larger version (134K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B. 52-year-old man with metastases from neuroendocrine tumor of
pancreas. Portal venous phase CT scan shows near-isoattenuation areas
peripheral to tumors. Upper portion of pancreatic mass is also visualized
(arrows).
|
|
Benign Focal Hepatic Lesions
Hemangioma
Hepatic hemangiomas may show THAD, probably because of an associated
arterioportal shunt [6].
Although, to our knowledge, no report gives pathologic proof of the
transtumoral route of an anteroportal shunt, this route may be the potential
communication between the hepatic artery and the portal vein (Figs.
5A and
5B). The arterioportal shunt
of a hemangioma is somewhat different from that of an HCC because most HCCs
accompanying an arterioportal shunt tend to be large tumors with portal vein
invasion. In small hepatic lesions less than 3 cm, the incidence of
arterioportal shunt is significantly higher in a small hemangioma (21%) than
in a small HCC (4%) [3].

View larger version (115K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A. 63-year-old man with hemangioma. Hepatic arterial phase CT
scan shows homogeneous high-attenuation mass in left lobe and concomitant
transient hepatic attenuation difference (THAD). Peripheral small portal vein
branch (arrow) is visualized early in area of THAD.
|
|
Focal Nodular Hyperplasia
Focal nodular hyperplasia is supplied by an anomalous enlarged hepatic
artery and is neither supplied nor drained by the portal vein. We experienced
a case of focal nodular hyperplasia associated with a transient low
attenuation peripheral to the tumor on the hepatic arterial phase image (Figs.
6A and
6B).

View larger version (123K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6A. 28-year-old man with focal nodular hyperplasia. Hepatic
arterial phase CT scan shows high-attenuation mass in anterior segment.
Low-attenuation area is noted peripheral to tumor (arrows). It may be
assumed that anomalous enlarged hepatic artery "siphons" blood
flow to peripheral portion of tumor.
|
|

View larger version (123K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6B. 28-year-old man with focal nodular hyperplasia. On portal
venous phase CT scan, tumor still shows high attenuation, and subtle
low-attenuation transient hepatic attenuation difference (THAD).
|
|
Pyogenic Abscess
The incidence of THAD of a pyogenic abscess shows some variation according
to the results of researchers (3067%)
[7,
8]. The THAD in a pyogenic
abscess may be attributed to portal vein thrombosis or stenosis due to
periportal inflammation [7]
(Figs. 7A,
7B, and
7C) or localized hepatic
venous obstruction caused by acute inflammation of the hepatic parenchyma
surrounding the abscess [8].
Most THADs of pyogenic abscessesas well as the pyogenic abscess
itselfdecrease in size or disappear after antibiotic treatment, which
alleviates the inflammation of the portal tract
(Fig. 7C).

View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7A. 45-year-old man with pyogenic abscess. Hepatic arterial phase
CT scan shows wedge-shaped high-attenuation area containing target lesion in
right lobe. Note partial thrombosis of portal vein branch
(arrow).
|
|

View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7C. 45-year-old man with pyogenic abscess. On follow-up hepatic
arterial phase CT scan obtained 1 month after the scan shown in B,
pyogenic abscess (arrows) is noted only on further cranial scans.
THAD has also decreased and is less conspicuous.
|
|
Focal Eosinophilic Necrosis
Recently, imaging findings of focal eosinophilic necrosis attracted
considerable attention because this condition often gives rise to a diagnostic
dilemma in daily practice. It more frequently shows a fuzzy margin, subtle
hypoattenuation, and a nonspheric shape than does a metastasis (Figs.
8A,
8B, and
8C). As far as we know, there
is no report about the THAD in focal eosinophilic necrosis. Pathologically, it
is a focal area of hepatocellular necrosis caused by severe eosinophilic
infiltration of the perivascular space. Therefore, one may assume that
eosinophilic infiltration of the perivascular space may be the cause of the
THAD in focal eosinophilic necrosis.

View larger version (103K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8A. 63-year-old man with focal eosinophilic necrosis. Hepatic
arterial phase serial CT scans show wedge-shaped high-attenuation area and
small low-attenuation lesion (arrow) in right lobe.
|
|

View larger version (96K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8B. 63-year-old man with focal eosinophilic necrosis. On portal
venous phase serial CT scans, transient hepatic attenuation difference (THAD)
associated with focal eosinphilic necrosis is not present.
|
|

View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 8C. 63-year-old man with focal eosinophilic necrosis. Follow-up
hepatic arterial phase CT scan obtained 2 months after the scan shown in
B does not show definite low-attenuation lesion or THAD, as was seen on
previous CT scan (B).
|
|
Tumorous Versus Nontumorous THAD
On hepatic arterial phase images, a high-attenuation focal hepatic lesion
of cirrhotic liver is usually HCC. However, nontumorous THAD in a cirrhotic
liver has a similar appearance. A wedge shape, a straight-line margin, and the
presence of normal vessels coursing through the lesion on hepatic arterial
phase images make a diagnosis of THAD very likely. Portal venous phase images
have an important role because most hypervascular tumors are seen as low
attenuations, whereas THADs are seen as normal attenuations on portal venous
phase images (Figs. 9A,
9B,
9C, and
9D). If there is any doubt
about the diagnosis of THAD on dynamic CT, MRI may solve the problem. Normal
signal intensity on T1- and T2-weighted images excludes hypervascular tumor
(Figs. 9C and
9D). Another important cause
of THAD is the "third-inflow tract." Aberrant gastric venous
drainage into the hepatic segment IV and aberrant cystic venous drainage into
the gallbladder fossa are the commonly encountered third-inflow tracts. Focal
hepatic lesions are not always associated with THAD and vice versa. In some
cases, it is impossible to define the specific cause of THAD (Figs.
10A,
10B, and
10C).

View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9C. 40-year-old woman with idiopathic transient hepatic
attenuation difference. T1-weighted (C) and T2-weighted (D)
images do not show definite focal hepatic lesion. Hepatic arterial phase CT
scan (not shown) obtained 6 months later showed no interval change in small
enhancing lesion in right lobe.
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9D. 40-year-old woman with idiopathic transient hepatic
attenuation difference. T1-weighted (C) and T2-weighted (D)
images do not show definite focal hepatic lesion. Hepatic arterial phase CT
scan (not shown) obtained 6 months later showed no interval change in small
enhancing lesion in right lobe.
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10C. 63-year-old woman with hemangioma. On slightly caudal hepatic
arterial phase CT scan, small dense enhancing nodule (arrow) is
noted. It is impossible to determine whether transient hepatic attenuation
difference (THAD) is secondary to hemangioma or to aberrant gastric vein
drainage.
|
|
Conclusion
THADs of focal hepatic lesions reflect a change in the dual blood supply of
the liver adjacent to the lesions. Benign focal hepatic lesions and malignant
tumors may be the causes of THADs. Radiologists should be familiar with the
dual-phase CT appearances of THADs to avoid the false-positive diagnosis of
pseudolesions and not to overestimate the extent of the disease.
Acknowledgments
We thank Bonnie Hami, department of radiology, University Hospitals Health
System, Cleveland, OH, for editorial assistance in preparing the
manuscript.
References
- Itai Y, Hachiya J, Makita K, Ohtomo K, Kokubo T, Yamauchi T.
Transient hepatic attenuation differences on dynamic computed tomography.
J Comput Assist Tomogr1987; 11:461
-465[Medline]
- Okuda K, Musha H, Yamasaki T, et al. Angiographic demonstration of
intrahepatic arterio-portal anastomoses in hepatocellular carcinoma.
Radiology1977; 122:53
-58[Abstract]
- Byun JH, Kim TK, Lee CW, et al. Arterioportal shunt: prevalence in
small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at
two-phase helical CT. Radiology2004; 232:354
-360[Abstract/Free Full Text]
- Kim TK, Choi BI, Han JK, Jang HJ, Cho SG, Han MC. Peripheral
cholangiocarcinoma of the liver: two-phase spiral CT findings.
Radiology 1997;204
: 539-543[Abstract/Free Full Text]
- Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y.
Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and
dynamic MRI. J Comput Assist Tomogr1999; 23:670
-677[Medline]
- Kim KW, Kim TK, Han JK, Kim AY, Lee HJ, Choi BI. Hepatic
hemangiomas with arterioportal shunt: findings at two-phase CT.
Radiology2001; 219:707
-711[Abstract/Free Full Text]
- Gabata T, Kadoya M, Matsui O, et al. Dynamic CT of hepatic
abscesses: significance of transient segmental enhancement.
AJR 2001;176:675
-679[Abstract/Free Full Text]
- Mathieu D, Vasile N, Fagniez PL, Segui S, Grably D, Larde D.
Dynamic CT features of hepatic abscesses. Radiology1985; 154:749
-752[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Colagrande, N. Centi, R. Galdiero, and A. Ragozzino
Transient Hepatic Intensity Differences: Part 1, Those Associated with Focal Lesions
Am. J. Roentgenol.,
January 1, 2007;
188(1):
154 - 159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Colagrande, N. Centi, R. Galdiero, and A. Ragozzino
Transient Hepatic Intensity Differences: Part 2, Those Not Associated with Focal Lesions
Am. J. Roentgenol.,
January 1, 2007;
188(1):
160 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Bittle and F. S. Chew
Imaging of Hepatocellular Carcinoma: Self-Assessment Module
Am. J. Roentgenol.,
June 1, 2006;
186(6_Supplement_1):
S431 - S433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Bittle and F. S. Chew
Radiological Reasoning: Incidentally Discovered Liver Mass
Am. J. Roentgenol.,
June 1, 2006;
186(6_Supplement_1):
S434 - S441.
[Abstract]
[Full Text]
[PDF]
|
 |
|